GSK’s Anemia Drug Gets FDA Nod Only for Patients on Dialysis - Bloomberg

GSK's anemia pill, Jesduvroq, approved by US FDA for chronic kidney disease patients on dialysis, limiting its market and revenue potential. GSK shares increased by up to 1.2% in London.